mannanbind
lectin
mbl
member
collectin
belong
ctype
lectin
superfamili
import
patternrecognit
receptor
innat
immun
system
overal
polypeptid
structur
mbl
includ
cysteinerich
ntermin
domain
collagenlik
region
neck
region
ctermin
carbohydr
recognit
domain
crd
crd
shown
bind
mannos
mannan
fucos
nacetylglucosamin
cluster
crd
render
oligomer
thought
suitabl
bind
polymer
sugar
microb
inde
mbl
select
recogn
sugar
present
pathogen
bacteria
virus
yeast
leishmania
via
crd
addit
sever
line
evid
suggest
mbl
inhibit
influenza
viru
infect
independ
complement
activ
group
show
mbl
interfer
viral
attach
host
cell
thu
affect
viral
spread
releas
mbl
encod
singl
gene
human
rodent
encod
two
gene
mbla
mblc
two
form
rodent
mbl
bear
homolog
display
distinct
overlap
ligandbind
specif
mbl
mainli
synthes
hepatocyt
present
liver
serum
howev
extrahepat
express
mbl
report
variou
tissu
inde
nonhepat
mous
mblc
mmblc
express
highest
small
intestin
known
intestin
epitheli
cell
iec
produc
cytokin
chemokin
crucial
recruit
activ
immun
cell
taken
togeth
find
indic
mmblc
express
iec
may
contribut
host
defens
intestin
microorgan
shigella
gramneg
bacilli
caus
bacillari
dysenteri
shigellosi
human
especi
develop
countri
interact
shigella
iec
trigger
import
signal
initi
amplif
acut
mucos
inflammatori
respons
studi
investig
characterist
direct
antibacteri
activ
mmblc
independ
complement
activ
opson
follow
intragastr
ig
inocul
invas
shigella
flexneri
balbc
mice
lyophil
cultur
flexneri
obtain
institut
microbiolog
epidemiolog
academi
militari
medic
scienc
beij
china
use
throughout
experi
streptomycinresist
mutant
flexneri
isol
use
gradient
plate
techniqu
appli
femal
balbc
mice
laboratori
anim
center
southern
medic
univers
guangzhou
peopl
republ
china
crd
fragment
obtain
pcr
plasmid
contain
mmblc
cdna
clone
liver
balbc
mous
laboratori
target
gene
insert
prokaryot
express
vector
petcmpketodeoxyocton
synthetas
ck
express
escherichia
coli
recombin
crd
protein
express
petck
purifi
niaffin
chromatographi
ammonium
sulfat
precipit
respect
antiserum
crd
obtain
rabbit
immun
recombin
ckscrd
protein
express
petck
specif
antibodi
verifi
use
recombin
thioredoxin
trx
crd
protein
express
purifi
affin
chromatographi
protein
gsepharos
column
pharmacia
ge
healthcar
freiburg
germani
anticrd
polyclon
antibodi
specif
mmblccrd
purifi
protein
g
chromatographi
dialyz
normal
salin
overnight
antibodi
concentr
determin
measur
absorb
nm
recombin
trxcrd
protein
solut
ml
prepar
mg
mm
buffer
mm
mm
ph
fitc
mg
st
loui
mo
usa
dissolv
dimethyl
sulfoxid
ad
incub
h
constant
shake
room
temperatur
free
fitc
remov
dialysi
overnight
trisbuff
salin
tb
buffer
mm
nacl
ph
trx
express
vector
label
fitc
use
procedur
shigella
flexneri
wash
three
time
tb
suspend
ml
tb
contain
tetrarhodamin
isothiocyan
tritc
flurochrom
incub
h
constant
shake
room
temperatur
tritc
flexneri
incub
fitclabel
recombin
trxcrd
protein
h
tbsedta
mm
mm
nacl
ph
mm
mm
nacl
ph
buffer
respect
fitctrx
protein
use
control
polyclon
antibodi
block
studi
group
given
anticrd
antibodi
normal
rabbit
igg
control
fluoresc
visual
olympu
fluoresc
microscop
iec
isol
use
modif
method
kristin
cowork
small
intestin
fragment
balbc
mice
cut
fragment
incub
h
room
temperatur
shaker
platform
hbss
contain
u
collagenas
xia
per
millilit
mg
dispas
per
millilit
bsa
mg
soybean
trypsin
inhibitor
per
millilit
digest
cell
wash
three
time
centrifug
g
min
dmem
plu
sorbitol
cell
cultur
plate
one
hour
plate
cell
cultur
surfac
coat
matrigel
epitheli
cell
cultur
phenolredfre
dmem
follow
addit
mg
insulin
per
millilit
heparin
ng
epiderm
growth
factor
peprotech
rocki
hill
nj
usa
per
millilit
mm
hepe
mm
glutamin
u
penicillin
per
millilit
streptomycin
per
millilit
dglucos
fetal
bovin
serum
cell
cultur
period
supplement
medium
maintain
volum
millilit
per
well
confirm
epitheli
natur
cell
express
cytokeratin
determin
use
fitclabel
monoclon
anticytokeratin
antibodi
shigella
flexneri
incub
trxcrd
protein
min
ad
cell
cultur
meanwhil
growth
medium
cell
replac
fresh
medium
control
flexneri
given
without
trxcrd
protein
antibodi
block
studi
group
given
anticrd
antibodi
incub
bacteria
cell
cultur
incub
bacteria
h
analysi
cytokin
cell
cultur
supernat
conduct
use
mous
inflamm
cytometr
bead
array
kit
bender
medsystem
vienna
austria
facscalibur
flow
cytomet
follow
cytokin
measur
monocyt
chemoattract
tumor
necrosi
intestin
tissu
dissect
normal
mous
wash
tb
tissu
entir
embed
optim
cut
temperatur
oct
tissuetek
mile
elkhart
usa
rapidli
frozen
dri
ice
cut
mount
polylysineco
glass
slide
warm
room
temperatur
slide
incub
tritclabel
flexneri
h
bacteria
incub
trxcrd
protein
h
control
antibodi
block
assay
section
incub
anticrd
antibodi
infect
intestin
epitheli
tissu
visual
use
fitclabel
monoclon
anticytokeratin
antibodi
fluoresc
visual
olympu
fluoresc
microscop
tissu
dissect
mice
perfus
ml
pb
mm
mm
mm
mm
ph
subsequ
ml
pb
contain
pfa
tissu
embed
oct
compound
frozen
cut
mount
polylysineco
glass
slide
endogen
peroxidas
activ
quench
incub
section
min
pb
contain
block
nonimmun
goat
serum
h
room
temperatur
section
incub
anticrd
dilut
pb
concentr
h
wash
pb
contain
tween
section
incub
hrplabel
antirabbit
igg
polyclon
antibodi
vector
laboratori
ca
usa
h
chromogen
substrat
use
diaminobenzidin
vector
laboratori
section
counterstain
mayer
hematoxylin
two
day
infect
anim
given
mg
erythromycin
mg
streptomycin
ml
water
ig
kept
abrosia
day
infect
viabl
shigella
organ
agar
cultur
suspend
ml
normal
salin
fed
ig
mice
given
mg
anticrd
antibodi
intraven
mg
antibodi
oral
administr
h
infect
normal
rabbit
igg
use
control
steril
water
contain
mg
erythromycin
mg
streptomycin
per
millilit
suppli
ad
libitum
throughout
entir
experi
anim
kill
decapit
h
treatment
tissu
obtain
weight
tissu
treat
homogen
ml
steril
pb
sampl
serial
dilut
plate
luria
bertani
agar
lb
agar
plate
contain
streptomycin
colonyform
unit
determin
lb
plate
incub
h
amount
bacteria
standard
per
gram
tissu
sampl
immedi
fix
pfa
dehydr
embed
paraffin
sequenti
section
taken
variou
level
sampl
stain
immunostain
use
evalu
inflammatori
respons
briefli
histosect
deparaffin
rehydr
endogen
peroxidas
block
hydrogen
peroxid
methanol
satur
achiev
incub
nonimmun
goat
serum
incub
carri
overnight
biotinantimous
antibodi
biolegend
san
diego
ca
usa
rat
antimous
mab
biolegend
biotinantimous
mab
hycult
biotechnolog
uden
netherland
respect
hrp
conjug
ad
incub
carri
h
chromogen
substrat
diaminobenzidin
vector
laboratori
section
counterstain
mayer
hematoxylin
mice
score
individu
histolog
examin
perform
two
independ
investig
blind
sourc
treatment
histolog
score
follow
total
histolog
score
repres
sum
epithelium
infiltr
score
rang
oneway
analysi
varianc
use
analysi
statist
signific
cytokin
level
student
ttest
cytokin
level
use
two
independ
group
comparison
error
bar
repres
standard
error
mean
p
consid
statist
signific
nonparametr
test
use
determin
statist
signific
differ
bacteria
adhes
histolog
score
number
invad
bacteria
intestin
tissu
test
use
two
independ
group
comparison
probabl
p
use
defin
signific
bind
fitclabel
trxcrd
protein
tritclabel
flexneri
illustr
fig
buffer
use
bright
green
fluoresc
produc
fitclabel
protein
aggreg
bacteria
seen
fluoresc
microscopi
howev
bind
trxcrd
flexneri
detect
incub
carri
tbsedta
buffer
shown
trx
express
bind
flexneri
buffer
fig
indic
mmblccrd
protein
specif
bind
flexneri
calciumdepend
manner
consist
previou
report
next
evalu
whether
polyclon
antibodi
mmblccrd
protein
prevent
bind
crd
protein
bacteria
affinitypurifi
antibodi
mmblccrd
protein
could
bind
recombin
mmblacrd
indic
immunoblot
analysi
supplementari
figur
data
avail
intern
immunolog
onlin
antibodi
inhibit
effect
bind
fitctrxcrd
protein
flexneri
vitro
fig
wherea
normal
rabbit
igg
fail
fig
confirm
mmblc
express
intestin
mucosa
immunohistochem
stain
perform
use
anticrd
antibodi
pfafix
section
obtain
normal
balbc
mice
shown
fig
mmblc
stain
observ
villou
epitheli
cell
throughout
small
intestin
agre
previou
report
meanwhil
result
also
verifi
antibodi
recogn
mmblc
vivo
activ
primari
iec
assess
measur
cytokin
level
cultur
medium
chose
cytokin
known
releas
activ
epitheli
cell
mostli
proinflammatori
properti
shown
fig
flexneri
induc
releas
secret
two
cytokin
reduc
recombin
trxcrd
protein
ad
cultur
shigella
flexneri
compound
anticrd
antibodi
stimul
secret
bacteria
howev
signific
differ
secret
two
group
surprisingli
found
assay
investig
whether
mmblc
influenc
bind
flexneri
intestin
tissu
vitro
horizont
frozen
section
small
intestin
mice
incub
bacteria
shown
fig
trxcrd
protein
block
adhes
tritclabel
flexneri
intestin
epitheli
tissu
complet
effect
anticrd
antibodi
bacteri
adhes
also
investig
microscop
count
data
count
five
field
three
separ
slide
show
number
bacteria
adher
surfac
intestin
mucosa
anticrd
exist
littl
test
whether
mmblc
protect
intestin
mucosa
bacteri
invasionassoci
damag
mice
treat
without
anticrd
antibodi
prior
flexneri
infect
intestin
tissu
section
stain
hematoxylin
eosin
analyz
light
microscopi
minim
damag
intestin
morpholog
anim
obviou
patholog
chang
seen
untreat
mice
mice
receiv
normal
rabbit
igg
howev
mice
receiv
anticrd
antibodi
infect
display
damag
intestin
tissu
indic
infiltr
mononuclear
leukocyt
polymorphonuclear
neutrophil
hemorrhag
fig
intestin
morpholog
appear
normal
mice
receiv
anticrd
antibodi
without
bacteri
infect
data
shown
consid
anticrd
influenc
complement
activ
vivo
supplementari
figur
avail
intern
immunolog
onlin
suggest
sever
bacteri
infect
may
result
recognit
function
mblc
block
shown
fig
tissu
section
prepar
untreat
mice
fig
mice
treat
either
normal
rabbit
igg
fig
anticrd
antibodi
fig
subject
immunohistochem
stain
untreat
anim
treat
normal
rabbit
igg
flexneri
infect
show
neg
stain
intestin
mucosa
anticrd
antibodi
treatment
result
signific
increas
level
howev
stain
use
rat
antimous
mab
biotinantimous
mab
section
intestin
sampl
data
shown
consid
flexneri
stimul
secret
primari
cultur
iec
vitro
indic
may
come
infiltr
inflammatori
cell
iec
mucos
surfac
first
line
defens
microbi
pathogen
abil
shigella
invad
colon
intestin
epithelium
associ
intens
inflammatori
respons
lead
destruct
colon
mucosa
central
shigellosi
order
assess
whether
mmblc
express
iec
affect
shigella
invas
intestin
mucosa
mice
treat
antibodi
mmblccrd
infect
streptomycinresist
strain
flexneri
shown
fig
small
number
streptomycinresist
flexneri
recov
intestin
tissu
untreat
mice
mice
receiv
control
igg
howev
administr
neutral
antibodi
significantli
increas
number
bacteria
recov
intestin
tissu
suggest
mmblc
express
intestin
epithelium
contribut
host
defens
flexneri
invas
mbl
evolutionarili
conserv
host
defens
protein
act
broadspectrum
recognit
molecul
wide
varieti
infecti
agent
studi
explor
role
mbl
relat
acquisit
infecti
organ
suscept
natur
associ
clinic
cours
sever
present
studi
demonstr
mmblc
directli
interact
flexneri
mmblc
intestin
villou
epitheli
cell
involv
protect
bacteri
infect
result
support
welldocu
role
mblc
host
defens
number
studi
shown
low
level
mbl
contribut
sever
ill
infect
pathogen
bacteria
neisseria
meningitidi
staphylococcu
aureu
streptococcu
pneumonia
anim
studi
also
show
mblnull
mice
inde
highli
suscept
aureu
pseudomona
aeruginosa
system
infect
intestin
epithelium
allow
nutrient
water
absorpt
also
provid
barrier
infect
iec
mucos
surfac
first
line
microbi
pathogen
studi
also
confirm
previou
report
rel
abund
express
mmblc
small
intestin
may
implic
protect
function
mmblc
small
intestin
multipl
mechan
mbl
involv
host
defens
pathogen
infect
kill
pathogen
activ
complement
cascad
function
opsonin
promot
phagocyt
clearanc
direct
opson
bind
lectin
receptor
phagocyt
howev
human
mbl
inhibit
type
influenza
viral
infect
spread
independ
complement
activ
furthermor
shown
mbl
capabl
block
interact
hiv
dendrit
cellspecif
intercellular
adhes
nonintegrin
express
dendrit
cell
therebi
inhibit
viru
transmiss
present
studi
found
mmblc
directli
bind
flexneri
vitro
antibodi
specif
mmblccrd
abl
interfer
interact
mmblc
block
adhes
flexneri
intestin
tissu
vitro
mmblccrd
decreas
proinflammatori
cytokin
product
like
primari
iec
stimul
flexneri
importantli
use
antibodi
vivo
could
abolish
host
defens
flexneri
indic
damag
iec
increas
number
invad
bacteria
induc
higher
express
proinflammatori
cytokin
base
data
postul
mbl
may
directli
inhibit
interact
microorgan
target
cell
crd
support
evid
also
came
studi
gastrointestin
mucin
shown
compet
underli
epithelium
bind
pathogen
result
reduc
attach
pathogen
mucos
iec
colon
therefor
appear
mechan
competit
inhibit
commonli
use
host
protect
invas
pathogen
microorgan
abil
shigella
invad
colon
intestin
epithelium
vital
shigellosi
ospecif
polysaccharid
osp
outermost
domain
lp
shigella
shown
essenti
virul
factor
mediat
invas
iec
protect
antigen
involv
primari
step
bacteria
entri
previou
studi
show
mbl
bind
osp
moieti
klebsiella
lp
like
osp
bind
structur
flexneri
mmblc
iec
reproduc
shigella
infect
model
establish
mous
intestin
tract
elimin
normal
enter
flora
although
infect
mice
show
gross
sign
ill
mesenter
lymph
node
patholog
chang
variou
section
intestin
tract
indic
establish
chronic
infect
circumst
lack
mbl
predispos
immunocompet
host
bacteri
infect
set
immun
insuffici
low
level
mbl
produc
haplotyp
associ
enhanc
suscept
infect
observ
set
cancer
chemotherapi
upon
antibodi
block
vivo
observ
signific
increas
number
flexneri
intestin
tissu
follow
infect
compar
control
anim
treat
either
salin
normal
rabbit
igg
addit
express
proinflammatori
cytokin
found
elev
intestin
mucosa
consid
flexneri
could
stimul
express
iec
vitro
suppos
cytokin
may
secret
infiltr
inflammatori
cell
taken
togeth
studi
demonstr
mmblc
like
express
iec
directli
bind
flexneri
help
prevent
acut
intestin
damag
mice
support
notion
mmblc
particip
defens
mechanismor
machineri
invad
bacteria
pathogen
better
understand
mbl
may
lead
novel
approach
target
molecul
improv
antibacteri
host
defens
nation
natur
scienc
foundat
china
natur
scienc
foundat
guangdong
provinc
